BMP Inhibition in the Presence of LIF Differentiates Murine Embryonic Stem Cells to Early Neural Stem Cells.

Early mouse neural stem cells (NSCs) first appear in embryonic day E5.5 and express pluripotency markers Oct4, Sox2, Nanog and early neural marker Sox1. Early NSCs are a good model for understanding the role of various pathways that control initial neural commitment. However, a protocol for differentiation of mouse embryonic stem cells (ESCs) into early NSCs by adherent monolayer culture has not yet been established. Hence, in this study, we identified the combination of growth factors and small molecules that differentiated mouse ESCs into early NSCs and supported their proliferation. Leukaemia inhibitory factor (LIF) was the first factor to be tested and it was found that ESCs can differentiate into early neurogenic lineage in the presence of LIF. However, we found that the induction is weaker in the presence of LIF as compared to cells differentiated in its absence. GSK-3 inhibitor, along with BMP and TGF-β pathway inhibitor (dual SMAD inhibition), are commonly used to sequentially direct ESCs towards NSCs. However, when we used this combination, mouse ESCs failed to differentiate into early NSCs. We observed that by adding Wnt inhibitor to the combination of GSK-3 inhibitor, BMP inhibitor, TGF-β inhibitor and LIF, it was possible to differentiate ESCs into early NSCs. qRT-PCR analysis of early NSCs illustrated that they expressed key pluripotency genes Oct4 and Nanog, albeit at levels lower than non-differentiated ESCs, along with early neural markers Sox1 and Pax6.

[1]  J. O'Brien,et al.  Dual SMAD inhibition and Wnt inhibition enable efficient and reproducible differentiations of induced pluripotent stem cells into retinal ganglion cells , 2020, Scientific Reports.

[2]  M. García-Castro,et al.  Human neural crest induction by temporal modulation of WNT activation. , 2019, Developmental biology.

[3]  S. Kiani,et al.  Inhibition of glycogen synthase kinase 3 increased subventricular zone stem cells proliferation. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[4]  Ju Han Kim,et al.  Small molecule-based lineage switch of human adipose-derived stem cells into neural stem cells and functional GABAergic neurons , 2017, Scientific Reports.

[5]  F. Ding,et al.  Sequential Differentiation of Embryonic Stem Cells into Neural Epithelial-Like Stem Cells and Oligodendrocyte Progenitor Cells , 2016, PloS one.

[6]  Jiashun Zheng,et al.  Pharmacological Reprogramming of Fibroblasts into Neural Stem Cells by Signaling-Directed Transcriptional Activation. , 2016, Cell stem cell.

[7]  A. Salem,et al.  WNT/β-catenin signaling mediates human neural crest induction via a pre-neural border intermediate , 2016, Development.

[8]  K. Hansen,et al.  β-Catenin Regulates Primitive Streak Induction through Collaborative Interactions with SMAD2/SMAD3 and OCT4. , 2015, Cell stem cell.

[9]  Xiongfong Chen,et al.  LIF-dependent primitive neural stem cells derived from mouse ES cells represent a reversible stage of neural commitment. , 2013, Stem cell research.

[10]  Austin G Smith,et al.  Treatment of a Mouse Model of Spinal Cord Injury by Transplantation of Human Induced Pluripotent Stem Cell‐Derived Long‐Term Self‐Renewing Neuroepithelial‐Like Stem Cells , 2012, Stem cells.

[11]  Woong Sun,et al.  Rapid induction and long-term self-renewal of primitive neural precursors from human embryonic stem cells by small molecule inhibitors , 2011, Proceedings of the National Academy of Sciences.

[12]  Tetsuhiro Kikuchi,et al.  Small‐molecule inhibitors of bone morphogenic protein and activin/nodal signals promote highly efficient neural induction from human pluripotent stem cells , 2011, Journal of neuroscience research.

[13]  Ji Young Kim,et al.  Robust Enhancement of Neural Differentiation from Human ES and iPS Cells Regardless of their Innate Difference in Differentiation Propensity , 2010, Stem Cell Reviews and Reports.

[14]  Lin Chen,et al.  Short-term BMP-4 treatment initiates mesoderm induction in human embryonic stem cells. , 2008, Blood.

[15]  Michael Kyba,et al.  Canonical Wnt signaling is required for development of embryonic stem cell-derived mesoderm , 2006, Development.

[16]  E. Kroon,et al.  Efficient differentiation of human embryonic stem cells to definitive endoderm , 2005, Nature Biotechnology.

[17]  K. Mizuseki,et al.  Directed differentiation of telencephalic precursors from embryonic stem cells , 2005, Nature Neuroscience.

[18]  D. van der Kooy,et al.  Primitive neural stem cells from the mammalian epiblast differentiate to definitive neural stem cells under the control of Notch signaling. , 2004, Genes & development.

[19]  Austin G Smith,et al.  Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture , 2003, Nature Biotechnology.

[20]  Marius Wernig,et al.  In vitro differentiation of transplantable neural precursors from human embryonic stem cells , 2001, Nature Biotechnology.

[21]  A. Streit,et al.  Initiation of neural induction by FGF signalling before gastrulation , 2000, Nature.

[22]  A. Björklund,et al.  Cell replacement therapies for central nervous system disorders , 2000, Nature Neuroscience.

[23]  Ryan M. Anderson,et al.  The organizer factors Chordin and Noggin are required for mouse forebrain development , 2000, Nature.

[24]  D. Shi,et al.  A truncated FGF receptor blocks neural induction by endogenous Xenopus inducers. , 1996, Development.

[25]  D. Melton,et al.  Inhibition of activin receptor signaling promotes neuralization in Xenopus , 1994, Cell.

[26]  H. Okano,et al.  Cell transplantation therapies for spinal cord injury focusing on induced pluripotent stem cells , 2012, Cell Research.

[27]  A. Hemmati‐Brivanlou,et al.  Neural induction. , 1999, Annual review of cell and developmental biology.